CAS: 1826865-46-6
![3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)…](https://static.cymitquimica.com/products/IN/thumb/DA01LJ2U.jpg)
3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-benzamide
CAS:1826865-46-6
Fórmula:
C36H48N6O3
Pureza:
98%
Peso molecular:
612.8047
Ref: IN-DA01LJ2U
| 5mg | 216,00 € | ||
| 10mg | 458,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 12 de Dezembro de 2024
ZLD 1039
CAS:1826865-46-6
ZLD 1039 is an activating compound that has been shown to modulate the immune system …
Fórmula:
C36H48N6O3
Pureza:
Min. 95%
Peso molecular:
612.8 g/mol
Ref: 3D-BYC86546
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Janeiro de 2025
ZLD1039
CAS:1826865-46-6
ZLD1039, an oral EZH2 inhibitor, shows strong PRC2 inhibition at low nanomolar IC50s, and halts …
Fórmula:
C36H48N6O3
Pureza:
99.82%
Cor e Forma:
Solid
Peso molecular:
612.8
Ref: TM-T29231
| 1mg | 35,00 € | ||
| 5mg | 72,00 € | ||
| 10mg | 102,00 € | ||
| 25mg | 221,00 € | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 30 de Janeiro de 2025
